Health Approves Protocol to Treat Children with Haemophilia A
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
Children up to six years old with haemophilia A may now receive treatment with emicizumab by the Unified Health System (SUS). The measure was officialized by the Ministry of Health through a decree published on Thursday (15/10) in the Official Journal of the Union and seeks to guide access to the drug throughout the country.The protocol establishes criteria for the diagnosis, inclusion and exclusion of patients, in addition to the conditions of …
The Ministry of Health approved protocol for the use of the medicine emicizumab in the treatment of children up to 6 years with haemophilia A who do not have inhibitors of factor VIII of blood clotting. The measure consists of a decree published in the edition of this Thursday (15) of the Official Journal of the Union. The document establishes criteria for diagnosis, inclusion and exclusion [...] The post Ministry approves protocol to treat chil…
The Ministry of Health has approved protocol for the use of the medicine emicizumab in the treatment of children up to 6 years with haemophilia A who do not have inhibitors of factor VIII of blood clotting. The measure consists of a decree published in the edition of this Thursday (15) of the Official Journal of the Union. Related news:Children with haemophilia will have less invasive therapy by SUS.The document establishes criteria for the diag…
The document establishes criteria for the diagnosis, inclusion and exclusion of patients, in addition to the conditions of treatment and the mechanisms of regulation, control and evaluation.
Ministry of Health approves national protocol for the use of the medicine emicizumab, which is applied under the skin and can reduce the frequency of bleeding
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
